This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Gilead Sciences, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jonah J Chang: Innovator in Cancer Treatment
Introduction
Jonah J Chang is a notable inventor based in Woodinville, WA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds.
Latest Patents
Jonah J Chang holds a patent for PARP7 inhibitors. This patent includes a compound of Formula I or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or deuterated analog thereof. Additionally, it encompasses a pharmaceutical composition comprising a compound of the present invention, along with a pharmaceutically acceptable excipient. The patent also outlines a method of treating cancer using these compounds.
Career Highlights
Jonah J Chang is currently employed at Gilead Sciences, Inc., where he continues to advance his research in pharmaceuticals. His work focuses on developing innovative treatments that can significantly impact cancer therapy.
Collaborations
Some of his notable coworkers include Stephen D Holmbo and Jesse M Jacobsen. Their collaborative efforts contribute to the ongoing research and development initiatives at Gilead Sciences, Inc.
Conclusion
Jonah J Chang is a dedicated inventor whose work in developing PARP7 inhibitors showcases his commitment to improving cancer treatment options. His contributions to the pharmaceutical industry are invaluable and highlight the importance of innovation in healthcare.